ホーム
マーケット
チャート&アイデア
Algo
ニュース
Store
ブローカー
ダウンロード
経済指標カレンダー
取引シグナル
Webターミナル
「
/
」を入力して検索:@user、$symbol
検索
ログイン
アカウントを作成
日本語
English
Русский
中文
Español
Português
Deutsch
한국어
Français
Italiano
Türkçe
IMCR
#1803
Immunocore Holdings plc American Depositary Shares
32.300
0
+2.28%
セクター:
ベース:
利益通貨:
日中レンジ
1年のレンジ
1日の変化
+2.28%
月次変化
-8.00%
6か月変化
-3.52%
1年の変化
-3.52%
以前の終値
31.580
0
Open
32.300
0
Bid
Ask
Low
32.300
0
High
32.300
0
ボリューム
17
マーケット
株
ヘルスケア
IMCR
Open full chart
Financials
Overview
明細書
Statistics
Dividends
Quarterly
Annual
Value
Q3, 24
Q4, 24
Q1, 25
Q2, 25
Q3, 25
Q4, 25
TTM
Key stats
Total common shares outstanding
50.03 M
50.07 M
50.23 M
50.39 M
50.53 M
50.7 M
—
Valuation ratios
Enterprise value
1.02 B
1.02 B
1.01 B
1.09 B
1.34 B
1.29 B
4.74 B
Price to earnings ratio
-32.77
-28.92
-69
-78.45
-63.74
-48.89
-260.07
Price to sales ratio
5.3
4.75
4.55
4.51
4.85
4.37
18.28
Price to cash flow ratio
74.98
56.59
71.45
48.6
231.2
163.13
514.39
Price to book ratio
1.07
4.09
1.03
1.07
1.21
4.59
7.89
Enterprise value to EBITDA ratio
-16.02
-15.41
-23.28
-25.66
-32.21
-30.58
-111.72
Profitability ratios
Return on assets %
0.01
0.01
0
0.01
0
0.02
0.03
Return on equity %
0.02
0.02
0.01
0.03
0
0.05
0.09
Return on invested capital %
7.37
23.11
3.42
28.25
-8.85
-122.87
-100.06
Gross margin %
99.44
99.61
99.11
98.94
99.51
97.41
394.97
Operating margin %
10.59
23.14
3.85
15.18
6.92
18.85
44.8
EBITDA margin %
-9.3
-21.76
-2.94
-14.39
-6.15
-18.05
-41.52
Net margin %
10.89
7.49
5.35
10.51
0.17
19.16
35.19
Liquidity ratios
Quick ratio
3.76
4.36
6.31
5.86
5.97
4.01
22.16
Current ratio
3.78
4.38
6.36
5.89
6
4.04
22.3
Inventory turnover
—
—
—
—
—
—
—
Asset turnover
0.08
0.08
0.09
0.09
0.09
0.1
0.38
Solvency ratios
Debt to assets ratio
—
—
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
—
—
Long term debt to total assets ratio
0.36
0.39
0.38
0.36
0.36
0.37
1.47
Long term debt to total equity ratio
1.03
1.08
1.03
1.01
0.99
1.03
4.07
Per share metrics
Operating cash flow per share
0.4
-0.28
0.01
0.52
-0.09
-0.22
0.21
EBIT per share
-0.16
-0.39
-0.07
-0.3
-0.14
-0.39
-0.9
EBITDA per share
-0.14
-0.37
-0.05
-0.28
-0.13
-0.37
-0.83
Total debt per share
—
—
—
—
—
—
—
Cash per share
17.07
9.12
16.11
17.55
17.7
17.16
68.53
Net current asset value per share
19.05
18.6
18.26
19.93
20.29
19.8
78.28
Tangible book value per share
7.15
7.22
7.29
7.72
7.87
7.57
30.45
Working capital per share
14.01
14.36
15.39
16.55
16.91
14.9
63.75
Book value per share
7.15
7.22
7.29
7.72
7.87
7.57
30.45
Immunocore Holdings plc - American Depositary Shares
Immunocore is a global commercial-stage biotechnology company, based in Oxfordshire, which researches and develops biological drugs using soluble T-cell receptor technology.
ニュース
Immunocore Holdings plc 2025 Q4 - Results - Earnings Call Presentation (NASDAQ:IMCR) 2026-02-25
Immunocore Holdings plc (IMCR) Q4 2025 Earnings Call Transcript
【決算速報】イミューノコアホールディングス、売上高は予想を下回り、利益は予想を下回る結果に
Immunocore Holdings earnings missed by $0.40, revenue fell short of estimates
JAZZ Stock Rises as Q4 Earnings & Sales Top Expectations
RXRX Q4 Loss Narrower Than Expected, Revenues Increase Y/Y, Stock Up
Repligen's Q4 Earnings Beat Estimates, Revenues Surge Y/Y
Apellis Q4 Loss Wider Than Expected, Revenues Decline Y/Y
メラノーマパイプライン進展でImmunocoreの決算発表控える
Immunocore earnings ahead as melanoma pipeline advances
Madrigal Q4 Earnings Miss, MASH Drug Sales Drive Top Line, Stock Down
Immunocore (IMCR) Upgraded to Strong Buy: Here's Why